Baker McKenzie Advises McKesson on USD 2.25 Billion Acquisition of Precision Medicine Group

Baker McKenzie acted as international counsel to McKesson Corporation on its acquisition of Precision Medicine Group, LLC. The transaction involves McKesson’s purchase of Precision Medicine Group, a global provider of clinical research and biopharma commercialization services, for approximately USD 2.25 billion. Baker McKenzie represented client(s) McKesson Corporation with a team composed by: Led by M&A Partner Darcy Down, the core team included: Corporate / M&A: Collin Stich, Angus Duncan; IP / Data: Adam Aft, Keo McKenzie, Robby Turner; Regulatory: Lois Sheng Liu, Jing Xu; Employment: Kimberly Franko, Benjamin Durst; Compensation: M'Alyssa Mecenas, Sesen Hailemichael, Jill Sparkman; Real Estate: Sarah Swain. Lawyers from around the Firm formed part of Baker McKenzie’s wider transactional team.

Menu

Baker McKenzie Advises McKesson on USD 2.25 Billion Acquisition of Precision Medicine Group

Read the full story

Menu

Baker McKenzie Advises McKesson on USD 2.25 Billion Acquisition of Precision Medicine Group

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads